Bronchiolitis Obliterans Syndrome
Showing 1 - 25 of >10,000
Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in
Recruiting
- Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
- Chronic Lung Allograft Dysfunction
- Sirolimus
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 28, 2023
Bronchiolitis Obliterans Trial (Study morphological and functional of respiratory epithelium)
Not yet recruiting
- Bronchiolitis Obliterans
- Study morphological and functional of respiratory epithelium
- (no location specified)
Nov 20, 2023
Clonogenic Epithelial Cell Populations in Bronchiolitis
Recruiting
- Bronchiolitis Obliterans
- Biospecimen Collection
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,
Not yet recruiting
- Bronchiolitis Obliterans Syndrome
- +3 more
- Belumosudil
- +4 more
-
Boston, Massachusetts
- +3 more
Jun 27, 2023
Bronchiolitis Obliterans Trial in Houston (Itacitinib, Itacitinib Adipate)
Recruiting
- Bronchiolitis Obliterans
- Itacitinib
- Itacitinib Adipate
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2023
Bronchiolitis Obliterans Trial (Exercise group)
Not yet recruiting
- Bronchiolitis Obliterans
- Exercise group
- (no location specified)
May 25, 2023
Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)
Recruiting
- Bronchiolitis Obliterans Syndrome
- Hematologic Malignancy
-
Hangzhou, Zhejiang, ChinaThe first Affiliated Hospital of Zhejiang University
Oct 18, 2022
Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute
Recruiting
- Chronic Graft vs Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans (BO) Trial in Basel (Nintedanib)
Recruiting
- Bronchiolitis Obliterans Syndrome (BOS)
- Bronchiolitis Obliterans (BO)
-
Basel, Switzerland
- +1 more
May 4, 2022
Bronchiolitis Obliterans Syndrome Trial in Belgium, Canada, United States (Itacitinib)
Active, not recruiting
- Bronchiolitis Obliterans Syndrome
-
Los Angeles, California
- +8 more
Oct 14, 2022
Bronchiectasis, Cystic Fibrosis, Primary Ciliary Dyskinesia Trial in Haifa (spirometry, Salbutamol, )
Recruiting
- Bronchiectasis
- +4 more
- spirometry
- +2 more
-
Haifa, IsraelRambam Health Campus
Jun 30, 2023
Respiratory Virus Testing and Home Spirometry for Screening of
Recruiting
- Bronchiolitis Obliterans Syndrome
- Hematopoietic and Lymphoid Cell Neoplasm
- Biospecimen Collection
- +2 more
-
Palo Alto, California
- +3 more
Aug 1, 2022
Bronchiolitis Obliterans Trial in Bordeaux (lung MRI)
Recruiting
- Bronchiolitis Obliterans
- lung MRI
-
Bordeaux, FranceCHU Bordeaux
Apr 11, 2022
Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis
Recruiting
- Bronchiolitis Obliterans Syndrome
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Feb 28, 2022
Pre-Bronchiolitis Obliterans Syndrome Trial in United States (ARINA-1, Standard of care only)
Recruiting
- Pre-Bronchiolitis Obliterans Syndrome
- ARINA-1
- Standard of care only
-
Los Angeles, California
- +10 more
Jan 30, 2023
Patients at Risk for Chronic Graft-Versus-Host Disease
Not yet recruiting
- cGVHD
- Non-Interventional
- (no location specified)
Jun 16, 2023
Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))
Recruiting
- Mesenchymal Stem Cells
- Mesenchymal Stem Cells (MSCs)
-
Shapingba, Chongqing, ChinaXinqiao Hospital
Nov 24, 2023
Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])
Completed
- Bronchiolitis Obliterans
- Graft Vs Host Disease
- Pirfenidone 267 MG [Esbriet]
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 8, 2022
Other Cancer Trial in Boston (ruxolitinib)
Recruiting
- Other Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)
Completed
- Chronic Graft-versus-host Disease (cGVHD)
- AMG 592
- Placebo
-
Aventura, FloridaResearch Site
May 16, 2023
Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)
Completed
- Chronic Graft-versus-Host Disease (cGVHD)
- AMG 592
- Placebo
-
Randwick, New South Wales, AustraliaResearch Site
May 23, 2023
Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)
Not yet recruiting
- Chronic Graft Versus Host Disease
-
Atlanta, GeorgiaNorthside Hospital
Sep 21, 2023
Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)
Recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Duarte, CaliforniaCity of Hope Site Number : 8400001
Nov 23, 2023
Chronic GVHD Trial in United States (drug, procedure, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Tampa, Florida
- +4 more
Aug 10, 2023